Episode Details

Depression may be more about brain circuitry than a simple chemical imbalance—and that changes everything. In this condensed version of Andrew Huberman’s Huberman Lab conversation with Dr. Nolan Williams, you’ll hear how transcranial magnetic stimulation (TMS), psychedelics like psilocybin, ketamine, MDMA, and ibogaine, and the new model of Psychiatry 3.0 may help rewire rigid neural networks tied to depression and PTSD. Compared with the full-length episode, this summary gets you the key ideas in minutes instead of the original long-form discussion. Learn how neurostimulation can affect the prefrontal cortex, why plasticity matters in treatment, what the evidence suggests for trauma recovery, and how Stanford Neuromodulation Therapy compresses months of care into just five days. Listen now to get the key ideas in minutes.